However, some of the broad industry growth trends which are playing out include low penetration levels as compared to the world average, shift to organized sector, government policy or initiatives and rising income levels.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale